Navigation Links
Epizyme, Inc. Provides Third Quarter 2013 Financial Results and Corporate Update
Date:10/22/2013

he Company's website beginning approximately two hours after the event.

About Epizyme, Inc.Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment.

For more information, visit www.epizyme.com and connect with us on Twitter at @EpizymeRx.EPIZYME, INC. CONSOLIDATED BALANCE SHEET DATA (UNAUDITED)(Amounts in thousands)September 30,December 31,20132012Cash and cash equivalents

$
39,575$
97,981Total assets

147,350103,511Deferred revenue

50,70669,445Redeemable convertible preferred stock (Series A, B and C)

-76,156Stockholders' equity (deficit)

87,283(51,126)EPIZYME, INC.CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)(Amounts in thousands except per share data)Three Months Ended September 30,Nine Months Ended September 30,2013201220132012Collaboration revenue

$
8,444$
5,331$
32,165$
36,327Operating expenses:Research and development

14,5849,25841,88227,385General and administrative

3,5871,6309,6645,175Total operating expenses

18,17110,88851,54632,560(Loss) income from operations

(9,727)4,443(19,381)3,767Other income (expense), net

235(32)69Net (loss) income

$
(9,704)$
4,448$
(19,413)$'/>"/>

SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Epizyme, Inc. Reports Second Quarter 2013 Financial Results
2. New Resource Provides Herb Industry With Sources of Quality Specifications
3. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
4. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
5. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
6. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
7. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
8. Insmed Incorporated Provides Corporate Update
9. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
10. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
11. Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Massachusetts , September 19, 2014 ... the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting  ... of science and medical research in the field of ... Merck KGaA, Darmstadt, Germany , today ... Innovation (GGI) for 2014. The awards were announced during ...
(Date:9/18/2014)... 2014 About POCT ... a clinical laboratory. It helps in making fast ... and medication. POCT is gaining popularity due to ... such as diabetes, heart disease, and obesity. It ... standardized to minimize errors during the diagnosis of ...
(Date:9/18/2014)... Ireland , September 18, 2014 ... and Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has ... "Biocompatible Materials - Global Strategic Business ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes ... in US$ Million by the following ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... the "Global N-acetylcysteine Industry Report 2014" ... Global N-acetylcysteine Industry Report 2014 is a professional ... the global N-acetylcysteine industry. The report ... definitions, classifications, applications and industry chain structure. The ...
Breaking Biology Technology:EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global N-acetylcysteine Industry Report 2014 2
... , , , ... • Cy • Alexa Fluor • TAMRA ... , Flexible and scalable uHTS programs ... fluorescent reagents for the task. This application note describes experiments to assess ...
... Key words: ... Analyzer • IN Cell Developer Toolbox, ... neurite outgrowth, plays a fundamental role in embryonic development, neuronal differentiation, ... neuropathological disorders as well as neuronal injury and regeneration. A variety ...
... , ... CypHer ™ 5, a pH sensitive dye, has ... been used to obtain dose-response and rank-order potency data for ... (2). For live-cell receptor internalization studies, an enhanced version of ...
Cached Biology Technology:Performance of fluorescent dyes with LEADseeker Multimodality Imaging System 2Performance of fluorescent dyes with LEADseeker Multimodality Imaging System 3Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 2Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 3Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 4Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 5Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 6Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 2Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 3Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 4Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 5Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 6
(Date:9/18/2014)... of Americans to undertake jaunts into the countryside each year ... within a century, according to new research. , Climate change ... United States as summer temperatures linger later into the year, ... and Biogeography . For instance, the paper birch a ... Hampshire could change color one to three weeks later ...
(Date:9/18/2014)... Va.Sept. 18, 2014Many Americans across racial and ethnic ... greatest impact on their day-to-day life, more so ... hearing and speech (57% of African-Americans, 49% of ... Hispanics). When asked which disease or ailment is ... ranked first among African-Americans followed by AIDS/HIV. ...
(Date:9/18/2014)... September 18, 2014 Elsevier, a world-leading provider ... services, and the Australasian Research Management Society (ARMS), ... scientists at the 5th Scopus Young Researcher of ... earlier today at the National Convention Centre and ... was attended by guests representing Australia,s and New ...
Breaking Biology News(10 mins):Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2
... Australian scientists studying the impact obesity has on ... before conceiving to assist with fetal development. ... of Zoology have discovered that a father,s obesity ... pregnancy success and reduced placental development. ...
... LONDON, ON The impact of bipolar disorder during pregnancy ... new study from Lawson Health Research Institute and Western University ... prospective research. Bipolar disorder is characterized by depression, ... its episodes are often concentrated during the height of the ...
... Research by Nosang Myung, a professor at ... Engineering, has enabled a Riverside company to develop ... quantities of harmful airborne substances. Nano Engineered ... completed the prototype which is based on intellectual ...
Cached Biology News:Thinking about kids? Man, you gotta shed the kilos 2Lawson researcher sings the baby blues 2'Electronic nose' prototype developed 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determine relative degree of protein binding to phosphoinositides...
PA coated Agarose beads LPA Beads...
Mouse monoclonal antibody to RNase L...
Biology Products: